LYFE Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

HiFiBiO Therapeuticshifibio.com in 𝕏May 2018 · $37.5M

HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.

AI & Machine LearningBiotechHealthtech

Liang Schweizer(Founder)in

Co-investorsB Capital Group B4 Capital Trinity Innovation Bioventure Singapore IDG Capital Legend Capital Nest.Bio Ventures +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.